跳至主要内容
临床试验/NL-OMON48360
NL-OMON48360已完成不适用

AN OPEN-LABEL, SINGLE-DOSE, SINGLE-PERIOD STUDY DESIGNED TO ASSESS THE MASS BALANCE RECOVERY, METABOLITE PROFILE AND METABOLITE IDENTIFICATION OF [14C]-OLOROFIM ADMINISTERED VIA THE ORAL ROUTE TO HEALTHY MALE SUBJECTS. - [14C]-Olorofim

F2G Biotech GmBH0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • healthy males
  • 18 - 55 years
  • 50 - 100 kilograms
  • BM) 18 - 30 kilograms/meter2
  • non smokers

排除标准

  • Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of
  • participation in another drug study within 90 days before the start of this
  • study or being a blood donor within 60 days from the start of the study. In
  • case of donating more than 1.5 liters of blood in the 10 months prior the start
  • of this study.

研究者

相似试验